GLP-1s are FDA-approved as an adjunct to nutrition and lifestyle therapy
Those antibodies could make future doses less effective, increase the risk of future reactions, or, in some therapeutic proteins, interfere with related natural proteins in the body
Results Aloxistatin reduces migration and proliferation rate of diseased HCFs Human cardiac fibroblasts (HCFs) are central effector cells in the development and progression of myocardial fibrosis, where their excessive proliferation, migration and extracellular matrix deposition drives scar formation progressively impairing cardiac performance [5]
Design, synthesis, biological screening, and molecular docking studies of piperazine-derived constrained inhibitors of DPP-IV for the treatment of type 2 diabetes
The results showed that TRIM37 conjugated mono- and poly-Ub chains to TRIM28 as an E3 ligase (Fig
Trachtenberg, J